John led a tremendous turnaround of Cangene and achieved a successful outcome for our stockholders.
SEDOR PHARMACEUTICALS, LLC
SEDOR PHARMACEUTICALS specializes in growth investment and turnaround opportunities in the pharmaceuticals and biologics industry. Led by 30-plus year healthcare industry veteran John Sedor, SEDOR PHARMACEUTICALS identifies and acquires pharmaceuticals and biologics companies and assets and applies its team’s deep development, operational, manufacturing, and commercialization expertise to create value for investors. SEDOR PHARMACEUTICALS licensed three clinical-stage compounds to establish its specialty pharmaceutical platform, has recently filed for FDA approval on its lead injectable compound CE-Fosphenytoin intended for the treatment of status epilepticus, and is developing its second injectable compound CE-Meloxicam intended for the treatment of acute post-surgical pain.